Covalon Technologies Ltd. COV.V

COV.V Company Overview

Covalon Technologies Ltd. is a Canada-based medical technologies company focused on advanced wound care, infection control, and medical device coating technologies. The company develops and commercializes products designed to improve patient outcomes, reduce healthcare-associated infections, and support healing in acute and chronic care settings. Covalon operates primarily within the healthcare and medical device industries, serving hospitals, clinicians, and healthcare systems through proprietary technologies and clinically focused product platforms.

The company’s primary revenue drivers include advanced wound dressings, collagen-based wound care products, antimicrobial technologies, and vascular access protection solutions. Key product families include IV Clear, VALGuard, CovaClear, and collagen dressing technologies used in wound management and infection prevention. Covalon has positioned itself around silicone adhesive technologies, antimicrobial coatings, and integrated vascular access solutions intended to reduce complications associated with catheters and surgical wounds. Founded in 2004 and headquartered in Mississauga, Ontario, the company evolved from a specialty coatings developer into a broader commercial-stage medical products company through internal development, commercialization efforts, and targeted acquisitions.